Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02456298 · ClinicalTrials.gov registry record · NA

Comparing Behavioral Assessments Using Telehealth for Children With Autism

A NA study of Autism Spectrum Disorder, sponsored by Matthew J O'Brien, PhD, BCBA-D.

Completed
Registry status
NA
Development phase
152
Enrollment target
1
Study location

NCT02456298 is a NA study of Autism Spectrum Disorder that has completed, run by Matthew J O'Brien, PhD, BCBA-D. The registered enrollment target is 152 participants, above the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02456298, a NA study of Autism Spectrum Disorder, has completed, sponsored by Matthew J O'Brien, PhD, BCBA-D.

COMPLETED
Registry status
NA
Development phase
152 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to determine the most efficient way for families to reduce problem behavior in their children with an autism spectrum disorder. Parents will be trained using telehealth to use applied behavior analysis (ABA) procedures to improve child behavior and communication. The study compares an established type of ABA assessment and treatment to a briefer, more streamlined version of this same type of assessment/treatment.

Conditions Studied

Interventions

  • BEHAVIORAL Standard FA+FCT
  • BEHAVIORAL Pragmatic FA+FCT

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2015-06
Est. Completion 2020-05-31
Phase NA

Sponsor

Matthew J O'Brien, PhD, BCBA-D

2 total trials

What the Registry Record Tells You About NCT02456298

The ClinicalTrials.gov registry entry for NCT02456298 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (13% higher). The listed sponsor is Matthew J O'Brien, PhD, BCBA-D, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Standard FA+FCT is the first listed.

NCT02456298 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT02456298 about?

NCT02456298 is a clinical study titled "Comparing Behavioral Assessments Using Telehealth for Children With Autism". The main purpose of this study is to determine the most efficient way for families to reduce problem behavior in their children with an autism spectrum disorder. Parents will be trained using telehealth to use applied behavior analysis (ABA) procedures to improve child behavior and communication. Th...

What is the current status of trial NCT02456298?

This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2015-06. Estimated completion is 2020-05-31.

What conditions does trial NCT02456298 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT02456298?

The interventions under investigation include: Standard FA+FCT (BEHAVIORAL), Pragmatic FA+FCT (BEHAVIORAL).

Who is sponsoring clinical trial NCT02456298?

This trial is sponsored by Matthew J O'Brien, PhD, BCBA-D, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02456298 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.